Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.98
-0.82 (-9.32%)
At close: Oct 13, 2026, 4:00 PM EDT
7.96
-0.02 (-0.25%)
After-hours: Oct 13, 2026, 7:53 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $565.85 million as of October 13, 2026. It is the 13,898th most valuable company in the world and the 2,659th biggest in the United States. Its market cap has increased by 126.70% in one year.
Market Cap
565.85M
Enterprise Value
310.23M
1-Year Change
126.70%
Global Rank
Country Rank
#2,659 United States
Category
ChartMarket Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $565.85M, an increase of 59.49%. That is a compound annual growth rate of 15.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 565.85M | 193.91% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Attovia Therapeutics | 666.05M |
| Wave Life Sciences | 646.32M |
| Olema Pharmaceuticals | 643.98M |
| Prime Medicine | 642.23M |
| Nuvectis Pharma | 641.53M |
| Climb Bio | 622.03M |
| Crescent Biopharma | 618.90M |
| Shattuck Labs | 611.21M |